Extensive experience spanning over 25 years in microbiology and immunobiology positions this expert as a specialist in vaccine research and development, particularly in the areas of viral and bacterial vaccines, immunotherapeutics, and disease prevention. Their work includes leadership of global vaccine development programs and contributions to the development and commercialization of multiple licensed and first-in-class vaccines. Prior consulting experience includes providing technical insight on vaccine performance, research methodologies, and product-related issues in dispute contexts.

Professional experience includes senior leadership roles such as Chief Technical Officer and Executive Director of Biological Research and Development, with global responsibility for vaccine research initiatives across the United States, Germany, and China. This work has involved oversight of regulatory approval processes, including USDA and international registration, analytical validation, and bioprocess development, as well as technology transfer and commercialization of vaccine platforms. The expert’s technical background includes vaccine combinations, potency assays, immune response evaluation, and infectious disease research across livestock and companion animal species.

Academic training includes a Doctor of Philosophy (Ph.D.) in Immunobiology and Veterinary Microbiology, a Master of Science in Veterinary Microbiology, and a Bachelor of Science in Microbiology. The expert holds more than 25 patents and patent applications and has authored an extensive body of peer-reviewed publications and scientific presentations. Professional affiliations include organizations such as the American Society for Microbiology and Sigma Xi, reflecting ongoing engagement in scientific advancement and innovation.